Immuron CEO, Steven Lydeamore to present at Bioshares

Rhea-AI Summary

Immuron Limited (ASX: IMC; NASDAQ: IMRN) announces that CEO Steven Lydeamore will be presenting at the 17th Bioshares Biotech Summit in Hobart, Australia on July 24th. A copy of the presentation slide deck is available on the company's website.

MELBOURNE, Australia, July 24, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Chief Executive Officer, Steven Lydeamore will be presenting at the 17th Bioshares Biotech Summit in Hobart, Australia on July 24^th.

A copy of the presentation slide deck is available on the Company’s website.

https://www.immuron.com.au/corporate-presentations/

This release has been authorised by the directors of Immuron Limited.

COMPANY CONTACT:

Steven Lydeamore
Chief Executive Officer
Ph: +61 (0)3 9824 5254
info@immuron.com  

About Immuron
Immuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and commercialising orally delivered targeted polyclonal antibodies for the treatment of infectious diseases.

For more information visit: http://www.immuron.com

FAQ

Who will be presenting at the 17th Bioshares Biotech Summit?

CEO Steven Lydeamore of Immuron Limited.

When and where will the summit take place?

The summit will take place in Hobart, Australia on July 24th.

Is the presentation slide deck available?

Yes, a copy of the presentation slide deck is available on the company's website.

How can I contact Immuron Limited?

You can contact Immuron Limited's CEO, Steven Lydeamore, at +61 (0)3 9824 5254 or info@immuron.com.